Home/Investors/Sofinnova Partners Sofinnova Partners
Biotech Investor · 18 portfolio companies
Portfolio Companies
| Company | Stage | Valuation | Focus |
|---|
| Sitryx Therapeutics | preclinical | — | Immunology, Oncology |
| Forward Therapeutics | preclinical | — | Immunology |
| F-star Therapeutics | Phase 2 | — | Oncology, Immunology |
| Asceneuron | Pre-clinical | — | Alzheimer's Disease, Parkinson's Disease |
| Inotrem | Phase 2 | — | Septic Shock, Inflammatory Diseases |
| Excelsior Sciences | Pre-clinical | — | — |
| Leucid Bio | Phase 1 | — | Oncology |
| May Health | Phase 3 | — | Women's Health, Reproductive Endocrinology |
| Latent Labs | Pre-clinical | — | — |
| Enthera Pharmaceuticals | Phase 1 | — | Type 1 Diabetes, Inflammatory Bowel Disease |
| Crescendo Biologics | Phase 1 | — | Oncology, Immunology |
| Actithera | Pre-clinical | — | Oncology |
| Elevara Medicines | Phase 2 | — | Rheumatoid Arthritis, Chronic Inflammatory Diseases |
| Myricx Bio | Pre-clinical | — | Oncology |
| Chroma Medicine | preclinical | — | Genetics & Genomics |
| GeneCure | phase-1 | — | Rare Disease, Genetics & Genomics |
| Vesalius Therapeutics | phase-1 | — | Metabolic, Cardiovascular |
| VitaCell Biologics | preclinical | — | Cardiovascular, Neurology |